- Gore R, Balthazar E, Ghahremani G, Miller F. CT features of ulcerative colitis and Crohn's disease. Am J Roentgen 1996;167:3-15.
- Schölmerich J, Schmidt E, Schümichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium ppmhexamethly propylene amine oxine as leukocyte label. Gastroenterology 1988;95:1287-93.
- Sciaretta G, Furno A, Mazzoni M, Basile C, Malaguti P. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Gut 1993;34:1364-9.
- Kolkman J, Flake T, Roos J, van Dijk D, Bannink I, den Hollander W, et al. Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative finding. Dig Dis Sci 1996;41:641-50.
- Sans M, Fuster D, Llach J, Lomen' f, Bordas J, Herranz R, et al. Optimization of technetium-99m HMPAO leucocyte scintigraphy in evaluation of active inflammatory bowel disease. Dig Dis Sci 2000;9:1828-35.
- Langholz E, Munkholm P, Haagen Nielsen O, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen County form 1962 to 1987. Scand J Gastroenterol 1991;26:1247-56.
- Munkholm P, Langholz E, Haagen Nielsen O, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609-14.
- Modigliani R, Mary J, Simon J, Cortot A, Soule J, Gendre J, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Gastroenterolgy 1990;98:811-8.
- Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63.
- Holdstock G, DuBoulay C, Smith C. Survey of the use of colonoscopy in inflammatory bowel disease. Dig Dis Sci 1984;29:731-4.
- Florén C, Benoni C, Willén R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 1995;22:459-62.
- Gomes P, Du Boulay C, Smith C, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986;27:92-5.
- Vilien M, Nielsen S, Jørgensen M, Binder V, Hvid-Jacobsen K, Berild D, et al. Leucocyte scintigraphy to localize inflammatory activity in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1992;27:582-6.
- Almer S, Franzén L, Peters A, Tjädermo M, Ekberg S, Granerus G, et al. Do technetium-99m hexamethylpropylene amine oximelabelled leucocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? Scand J Gastroenterol 1992;27:1031-8.
- Shoenut J, Semelka R, Silverman R, Yaffe C, Micflikier A. Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 1993;17:73-8.
- Shoenut J, Semelka R, Magro C, Silverman R, Yaffe C, Micflikier A. Comparison of a magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994;19:31-5.
- Kolkman J, Heitbrink M, Peña A, et al. Magnetic resonance imagining in inflammatory bowel disease: assessment of localisation and inflammatory activity [Abstract]. Gastroenterology 1994;106:A712.
- Semelka R, Shoenut J, Silverman R, Kroeker M, Yaffe C, Micflikier A. Bowel disease: prospective comparison of CT and 1.5-T pre-and postcontrast MR imaging with TI-weighted fat-suppressed and breath-hold FLASH sequences. J Magn Reson Imaging 1991;:1:625-32.
- Madsen S, Thomsen H, Munkholm P, Dorph S, Schlichting P. Active Crohn's disease and ulcerative colitis evaluated by low field magnetic resonance imaging. Scand J Gastroenterol 1998;33:1193-200.
- Umschaden H, Szolar D, Gasser J, Umschaden M, Haselbach H. Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 2000;215:717-25.
- D'Arienzo A, Scaglione G, Vicinanza G, Manguso F, Bennato R, Belfiore G, et al. Magnetic resonance imaging with ferumoxil, a negative superparamagnetic oral contrast agent, in the evaluation of ulcerative colitis. Am J Gastroenterol 2000;95:720-4.
- Low R, Francis IR, Politoske D, Bennett M, Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000;11:127-35.
- Rieber A, Wruk D, Potthast S, Nüssle K, Reinshagen M, Adler G, et al. Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional method. Int J Colorectal Dis 2000;15:176-81.
- Rieber A, Aschoff A, Nüssle K, Wruk D, Tomczak R, Reinshagen M, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 2000;10:1377-82.
- Kettritz U, Isaacs K, Warshauer D, Semelka R, Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 1995;21:249-53.
- Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2001;25:219-28.
- Madsen S, Thomsen H, Munkholm P, Schlichting P, Davidsen B. Magnetic resonance imaging in Crohn's disease. Early recognition of treatment response and relapse: a case repot. Abdom Imaging 1997;22:164-6.
- Madsen S, Thomsen H, Schlichting P, Dorph S, Munkholm P. Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging. Abdom Imaging 1999;24:232-9.
- Best W, Becktel J, Singleton J, Kern F. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 1976;70:439-44.
- Best W, Becktel J, Singleton J. Rederived values of the eight coefficient of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77:843-6.
- Powell-Tuck J, Bown R, Lennard-Jones J. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978;13:833-7.
- Kelbæk H, Linde J, Nielsen S. Evaluation of a new leucocyte labelling procedure with 99mTc-HMPAO. Eur J Nucl Med 1998;14:621-3.
- Wuff H, Schlichting P. MEDSTAT (version 2.12). Statistical program for the analysis of the results of controlled therapeutical trials and other types of clinical research. 2.12 ed. Copenhagen, Denmark: Astra. 1991.
- Blichert-Toft M, Mouridsen H, West Andersen K. From the Danish Breast Cancer Cooperative Group (DBCG). Clinical trials. Sem Surg Oncol 1996;12:32-8.
- Hunter C, Frelick R, Feldman A, Bavier A, Dunlap W, Ford L, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physicians Patient Log. Cancer Treat Rep 1987;71:559-65.
- Madsen S, Holm S, Davidsen B, Munkholm P, Schlichting P, Riis P. Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trials. J Intern Med 2000;248:461-73.
- Madsen S, Mirza M, Holm S, Hilsted K, Kampmann K, Riis P. Attitudes towards clinical research of participants and nonparticipants. J Intern Med 2002 (accepted for publication).
- van Oostayen J, Wasser MNJM, van Hogezand R, Griffioen G, Biemond I, Lamers CBHW, et al. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, an alpha(1)-antitrypsin clearance in feces. Am J Roentgen 1997;168:429-33.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 3